Elad Sharon, MD, MPH
eladsharonmd.bsky.social
Elad Sharon, MD, MPH
@eladsharonmd.bsky.social
#MedicalOncologist @DanaFarber posting on #immunotherapy, #drugdevelopment, #irAEs & #HealthEcon. Formerly @theNCI & #CancerMoonshot Adult ImmunoTx Co-Chair
Watching the opening session for the #FriendsOfCancerResearch Annual Meeting! First up: seamless trial designs for rare cancer drug development! You can watch live and online: secure-web.cisco.com/1-aSs6clrewX...
November 4, 2025 at 3:20 PM
Excited to be speaking on November 4th Friends of Cancer Research annual meeting (#FriendsAM25)! I will be speaking on #ContributionOfEffect (#COE) You can still register online: secure-web.cisco.com/1-aSs6clrewX...
November 4, 2025 at 3:51 AM
About to speak at the @theaacr.bsky.social annual meeting on side effects associated with cancer immunotherapy! If you are in Chicago, please come to S403b! It’s the place to be!
April 26, 2025 at 7:32 PM
Complacency = Complicity
April 2, 2025 at 3:07 PM
I went to a very competitive high school in Texas, but poisoning goats is where we drew the line… https://buff.ly/3W5cGZh
January 1, 2025 at 3:57 AM
Don’t forget to contribute to your child’s #529 plan by 12/31 if you are saving for college (in the USA anyway)… those state income tax benefits will be lost for 2024 if you forget…
December 26, 2024 at 4:20 PM
Some random photos from the “Walkipedia” next to our conference room at #TCGCrest meant to inspire the researchers at this new research institute in #Kolkata. Really great time talking about the science of immunotherapy!
December 13, 2024 at 9:38 AM
Listening to #SanchetShukla of @mdandersonnews here at the #ICANVAX24 meeting at #TCGCrest Great cartoon on MHC presentation too! https://buff.ly/4iq87T0
December 12, 2024 at 9:28 AM
Hearing from ⁦‪@MontefioreNYC‬⁩’s Professor #ChandanGuha about immunotherapy and radiation biology at the #ICANVAX24 meeting at #TCGCrest in Kolkata, India! Wonderful to see these international collaborations develop! https://buff.ly/4iq87T0
December 12, 2024 at 5:32 AM
One of the most important multi-cancer analyses on #ImmuneRelatedAdverseEvent grading and clinical outcome is out this week from @JNCI : https://buff.ly/499OIBj
November 26, 2024 at 3:54 AM